Who
Anup Marda
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Cabaletta Bio.
In numbers
- Trades disclosed
- 24
- Buys
- 1
- Sells
- 0
- Bought
- $50K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 24 Oct 2019
- Last trade
- 2 Mar 2026
- Last filed
- 2 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Mar 2026filed 2 Mar 2026 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —225,000 at $0.00 | filing |
| 2 Mar 2026filed 2 Mar 2026 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —225,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —139,282 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —139,282 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —66,463 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —66,463 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —24,711 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —24,711 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —100,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —135,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —135,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —150,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —130,000 at $0.00 | filing |
| 19 May 2025filed 19 May 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 3 Mar 2025filed 4 Mar 2025 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —145,000 at $0.00 | filing |
| 1 Mar 2024filed 4 Mar 2024 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 18 Jan 2023filed 27 Jan 2023 | CABA Cabaletta Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 18 Oct 2022filed 18 Oct 2022 | CABA Cabaletta BioBiotechnology | SEC FORM 4 Bought | $50K50,000 at $0.99 | filing |
News
No headline names them, or the companies they trade most, lately.